Different patterns of second‐line treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic): A multinational observational study

AIMS: The understanding of second‐line use of glucose‐lowering drugs (GLDs) in the general population with type 2 diabetes (T2D) treatment is important as recent results have shown cardiovascular benefits with sodium‐glucose cotransporter‐2 inhibitors (SGLT‐2i) and glucagon‐like peptide‐1 receptor a...

Descripción completa

Detalles Bibliográficos
Autores principales: Persson, Frederik, Bodegard, Johan, Lahtela, Jorma T., Nyström, Thomas, Jørgensen, Marit E., Jensen, Majken Linneman, Gulseth, Hanne L., Thuresson, Marcus, Hoti, Fabian, Nathanson, David, Norhammar, Anna, Birkeland, Kåre I., Eriksson, Johan G., Eriksson, Jan W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354817/
https://www.ncbi.nlm.nih.gov/pubmed/30815564
http://dx.doi.org/10.1002/edm2.36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354817/
https://www.ncbi.nlm.nih.gov/pubmed/30815564
http://dx.doi.org/10.1002/edm2.36

Ejemplares similares